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Objective: To evaluate any change in the operative and survival outcomes in patients undergoing a
right hepatectomy after adoption of the no-clamp technique using a radiofrequency dissecting sealer
(TissueLink™) in liver resection.
Methods: In all, 58 consecutive patients who underwent a right hepatectomy from July 2003 to Decem-
ber 2007 (Group 1) were compared with 66 consecutive patients who underwent a right hepatectomy
from January 1999 to June 2003 (Group 2). In group 1, a liver transection was performed with a cavitron
ultrasonic surgical aspirator (CUSA) and TissueLink™ without hilar clamping whereas in group 2, a liver
transection was performed with CUSA and diathermy with routine continuous hilar clamping.
Results: For the operative outcomes, there was significantly less blood loss (median 450 vs. 900 ml,
P < 0.001) in group 1. The complication rate was also significantly lower in group 1 (22.4% vs. 47.0%, P
= 0.004). In subgroup analysis for patients with hepatocellular carcinoma (HCC), the overall survival rate
was significantly better in group 1; 1-, 3- and 5-year survival rates were 78%, 72% and 57% in group 1
vs. 72%, 44% and 39% in group 2, respectively (P = 0.048).
Conclusions: When compared with the retrospective cohort, a right hepatectomy utilizing TissueLink™
without hilar clamping was feasible with potential benefits in surgical outcomes.
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Introduction
Bleeding is an important contributing factor for post-operative
morbidity and mortality after hepatectomy.1,2 The Pringle
manoeuver (or hilar clamping) is commonly used in controlling
hepatic inflow to decrease blood loss during liver resection.3–5
Nevertheless, hilar clamping may decrease cardiac output and
increase systemic vascular resistance during surgery.6 Moreover it
may cause ischaemic insult to the remnant liver, which is a signifi-
cant problem in cirrhotic patients.7,8 Although several studies have
analysed the effect on outcome after various methods of hilar
clamping during hepatectomy, the results have been inconclusive
and hence no consensus exists as to the optimal usage of hilar
clamping.6,9
In recent years, a number of new dissecting instruments have
been developed to facilitate liver resection with less blood loss.
TissueLink™ (TissueLink medical Inc., Dover, DE, USA) is a type
of saline-linked radiofrequency dissecting sealer. It employs
radiofrequency energy, which is transmitted to the target tissue
through saline dripping. It seals the intrahepatic vessels through
shrinkage of collagen at a temperature below 100°C and thus
prevents char formation. It has been shown to achieve better
haemostasis than conventional diathermy in hepatectomy.10,11
Prior to 2003 at the Prince of Wales Hospital, Hong Kong, it was
standard practice for a continuous hilar clamp to be applied
during parenchymal dissection for patients undergoing a right
hepatectomy. Parenchymal dissection and a transection was
then performed using the ultrasonic surgical aspirator (CUSA;
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ValleyLab, Boulder, Co, USA) and diathermy. Since early 2003,
parenchymal dissection and transection was performed using
CUSA and TissueLink™. Starting with a minor hepatectomy, the
blood loss during liver resection was noted to be very low even
without hilar clamping. Thus the standard technique from July
2003 for parenchymal dissection and transection during major
hepatectomy became CUSA and TissueLink™ without routine
hilar clamping.12
The present study was intended to determine whether these
changes in technique resulted in changes in the post-operative
outcomes and survival after a right hepatectomy.
Methods
All patients who underwent a right hepatectomy in the Prince of
Wales Hospital, Hong Kong during the period from 1st January
1999 to 31st December 2007 were included in the present study.
A right hepatectomy was defined as resection of the Couinaud’s
segments 5 to 8 (segment 1) according to the Brisbane classi-
fication.13 Patients who underwent a concomitant bile duct resec-
tion, bowel resection or extended right hepatectomy which
involved resection of segment 4 were excluded from the present
study. Patients were divided into two groups according to the
method of liver resection. From July 2003 to December 2007,
patients underwent a right hepatectomy with the use of a radiof-
requency dissecting sealer and CUSA without hilar clamping
(group 1) whereas from January 1999 to June 2003, patients
underwent a right hepatectomy with the use of CUSA, diathermy
and routine hilar clamping (group 2). The baseline characteristic,
intra-operative parameters and post-operative outcomes were
compared between the two groups. Outcomes of particular inter-
est were post-operative morbidity and mortality, operation time,
blood loss, transfusion rate, post-operative liver function, hospi-
tal stay and survival. Surgical complications were classified as
described by Dindo and colleagues.14 Post-operative hepatic
insufficiency was defined by the 50–50 criteria from Belghiti
et al.15 (bilirubin level >50 mmol/l and prothrombin time <50%
at post-operative day 5). Hepatic encephalopathy was defined as
an altered mental state as a result of impaired liver function,
evidenced by a rise in serum ammonia level. Liver failure was
defined as progressively increasing hyperbilirubinemia with
serum total bilirubin persistently 85 mmol/l.16 Operative mor-
tality was defined as death within the same admission for surgery
or death occurred within 30 days after surgery. A blood transfu-
sion was given if there was haemodynamic disturbance as a result
of a massive blood loss or when the haemoglobin level dropped
below 8.0 g/dl. Any blood given during surgery or within the
same admission after surgery was counted as a peri-operative
transfusion.
Surgical technique
All surgical procedures were performed by consultant-grade sur-
geons specialized in hepato-biliary surgery at a university hospital.
Operations were performed with a right subcostal incision with
an upward midline extension, and in selected patients this was
extended by a left subcostal incision. Intra-operative ultrasound
(Aloka, Tokyo, Japan) was used in all patients to define the
tumour, to exclude pre-operatively undetected lesions and to
mark the plane for a liver parenchymal transection. The central
venous pressure was ideally kept below 5 cm H2O.17–19 The
approach to liver mobilization was variable and left to the discre-
tion of the surgeon.
In group 1, hilar dissection was performed to ligate the
right hepatic artery and right portal vein if possible before liver
transection. Otherwise, the hepatic artery and portal vein
branches were ligated intra-hepatically during parenchymal
transection. Liver transection was performed with CUSA and a
radiofrequency dissecting sealer (TissueLink™) without hilar
clamping. In group 2, continuous hilar clamp was applied
during liver transection. The right hepatic artery and portal
vein were divided intra-hepatically during liver transection
either by a endovascular stapler or using a knife between
clamps with over sewing of both ends. A liver parenchymal
transection was performed with CUSA and diathermy. Larger
vessels and the bile duct were ligated separately in both groups.
Right hepatic veins were usually divided by endovascular sta-
plers. In most patients, tissue glue (Tisseel; Baxter, Vienna,
Austria) was sprayed onto the liver transection surface to
augment haemostasis and to decrease bile leak, although a recent
study showed that its routine use might not be justified.20
The decision to place abdominal drains was left to the operating
surgeons.
Statistical analysis
Data were expressed in mean  standard deviations (SD) or
median (range). Continuous variables were compared using Stu-
dent’s t-tests or Mann–Whiney U-test as appropriate; whereas
categorical variables were compared with c2 test or Fisher’s exact
test as appropriate. Survival curves of disease-free survival and
overall survival were calculated using the Kaplan–Meier method
and compared with a two-sided log-rank test in univariate analy-
sis. Multivariate analysis was performed by stepwise Cox regres-
sion in prognostic factors with P < 0.050 during univariate
analysis for survival analysis in patients with a hepatocellular car-
cinoma.A statistically significant result was defined as P < 0.05.All
statistical calculations were performed using SPSS 15.0 software
(SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics
In all, 124 patients were included in the analysis: 58 (47%) patients
belonged to group 1 whereas 66 (53%) patients belonged to group
2. The baseline characteristics between the two groups are shown
in Table 1.
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Operative outcomes
The operative outcomes are summarized in Table 2. In summary,
group 1 had less blood loss, a lower transfusion rate, a lower
complication rate and shorter hospital stay than group 2. The list
of complications according to Dindo’s description14 is shown in
Table 3.
Post-operative liver function
There was no significant difference in the pre-operative interna-
tional normalized ratio (INR), albumin and bilirubin levels
between the two groups. The mean bilirubin, INR and albumin
level at post-operative day 5 (D5) were used as surrogate markers
for post-operative recovery of liver function. The D5 albumin
level (g/l) was significantly higher in group 1 (group 1 vs. group
2 = 30.4  4.9 vs. 27.7  3.8, P = 0.002). The D5 INR, bilirubin
level and rate of hepatic insufficiency (group 1 vs. group 2 = 6.1%
vs. 12.2%, P = 0.487) were also higher in group 2, although results
did not reach statistical significance.
Subgroup analysis on heptocellular carcinoma
A total of 36 patients in group 1 and 50 patients in group 2 were
included for analysis. Baseline comparison between the two
groups is shown in Table 4. The median follow-up durations were
38.4 (0.8–80.1) and 25.7 (0.2–124.3) months in group 1 and 2,
respectively. The overall survival rate for patients with heptocel-
lular carcinoma (HCC) was significantly higher in group 1. The
Table 1 Baseline characteristics table
Group 1 (n = 58) Group 2 (n = 66) P-value
Age 51.5 (17–72) 54 (33–76) 0.174
Gender (M : F) 78% : 22% 89% : 11% 0.090
ASA score 0.254
I 21 (36%) 26 (39%)
II 33 (57%) 30 (45%)
III 4 (7%) 10 (15%)
Number of medical co-morbidity 1 (0–5) 0 (0–5) 0.607
Liver cirrhosis 14 (24%) 24 (36%) 0.141
Child's grading in cirrhotic patients (A/B) 14/0 23/1 1.000
Tumour size (cm) 6.9  3.3 6.0  2.8 0.117
Resection margin (cm) 1.6  1.3 1.4  1.4 0.623
Pathology
Hepatocellular carcinoma 36 (62%) 50 (76%)
Colorectal metastasis 14 (24%) 11 (17%)
Cholangiocarcinoma 4 (7%) 0 (0%)
Undifferentiated carcinoma 0 (0%) 1 (2%)
Metastatic gastrointestinal stromal tumour 1 (2%) 0 (0%)
Benign liver conditions 3 (5%) 4 (6%)
ASA, American Society of Anesthesiologists; medical co-morbidity included diabetes, hypertension, hyperlipidaemia, gout, ischaemic heart disease,
history of stroke, chronic obstructive pulmomary disease; Benign liver conditions included recurrent pyogenic cholangitis, focal nodular hyperplasia,
hepatic haemangioma and adenoma.
Table 2 Operative outcomes
Group 1 (n = 58) Group 2 (n = 66) P-value
Total operative time (min) 318  64 185  45 <0.001a
Clamp time (min) NA 20  8
Placement of the abdominal drain 28 (48.3%) 41 (62.1%) 0.122
Blood loss (ml) 450 (100–2400) 900 (186–11745) <0.001a
Transfusion rate 6 (10.3%) 17 (27.0%) 0.020a
Complications rate 13 (22.4%) 31 (47.0%) 0.004a
Hospital stay (days) 8 (5–36) 10 (6–69) 0.004a
Operative mortality 1 (1.7%) 4 (6.1%) 0.370
aStatistically significant result (P < 0.05).
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1-, 3- and 5-year survival rates were 78%, 72% and 57% in group
1 and 72%, 44% and 39% in group 2, respectively (P = 0.048).
(Fig. 1a) The disease-free survival rate was also significantly
higher in group 1. The 1-, 3- and 5-year disease-free survival rate
was 73%, 61% and 57% in group 1 and 47%, 31% and 26% in
group 2, respectively (P = 0.009) (Fig. 1b). Univariate and multi-
variate analysis on survival in HCC patients is shown in Table 5.
Group 2 and the presence of a satellite nodule were independent
prognostic factors for overall survival in HCC patients.
Effect of transfusion on complication and survival in
HCC patients
The complication rate was significantly higher in patients who
received a blood transfusion vs. those who did not receive a
transfusion; 14 (60.9%) vs. 30 (29.7%), P < 0.005. The wound
infection rate was also higher in patients who received a trans-
fusion 7 (30.4%) vs. those who did not 16 (12.9%), although it
did not reach statistical significance, P = 0.057. Excluding the
patients who received a transfusion in group 2, there was no
statistical significance in the complication rate between group 1
and 2; 13 (22.4%) vs. 19 (38.8%), P = 0.066. With regards to
survival in HCC patients, after excluding the patients who
received a transfusion in group 2, the overall survival rate was
still significantly better in group 1; 1-, 3- and 5-year survival
rates were 78%, 72% and 57% in group 1 vs. 69%, 39% and 36%
in group 2, P = 0.028.
Discussion
Pringle’s manoeuver is a traditional method used to reduce blood
loss during a hepatectomy.However, a surgeon’s main concern for
hilar clamping is the ischaemic–reperfusion injury to the remnant
liver and subsequent development of post-operative liver failure,
especially in cirrhotic patients. In order to preserve the liver func-
tion, some surgeons advocate a hepatectomy without hilar clamp-
ing,10,21 especially in a live donor hepatectomy.22–24 The present
study showed that a right hepatectomy without hilar clamping
was feasible and safe when combined with the use of CUSA and a
radiofrequency dissecting sealer. When compared with the retro-
spective cohort of routine hilar clamping with CUSA and
diathermy, it resulted in significantly less blood loss, less post-
operative complications, shorter hospital stay and even better sur-
vival in patients treated for HCC.
A formal right hepatectomy was chosen for comparison in the
present study because it is commonly performed. As the surgical
anatomy and the magnitude of surgery were standardized, it
allowed a fair comparison between the two techniques. In addi-
tion, all consecutive patients undergoing a right hepatectomy
from a single centre were studied, strengthening the validity of this
study and the comparative data. It should be acknowledged that
several other factors may have contributed to the observed differ-
ences.
These factors would include changes in the CVP, the method of
hepatic mobilization or indeed simply the extrahepatic ligation of
the right portal pedicle. However, given the retrospective nature of
this study, these were not able to be studied in detail.
Contrary to the most common belief, an interesting finding of
the present study was a significantly higher blood loss in the group
2 (median 900 vs. 450 ml, P < 0.001). It is the authors’ belief that
the likely explanation is the improvement in surgical technique
and the use of a radiofrequency dissecting sealer. From the authors
previous experience of 248 consecutive patients undergoing
partial hepatectomy, the radiofrequency dissecting sealer was
effective in hemostasis during a partial hepatectomy, even without
hilar clamping.12 Other studies also showed that a radiofrequency
dissecting sealer is effective in controlling bleeding during a hepa-
tectomy.10,11,21,24 Besides, without hilar clamping, there would not
be any time constraint with regard to ischaemic insult to the
remnant liver. As a result, surgeons would have more time for
meticulous haemostasis in group 1. In addition the TissueLink™
needs time to achieve secure haemostasis on the liver transection
surface. These were the main reasons for longer operating time in
group 1.
Previous studies showed that a cirrhotic liver can tolerate up to
30–45 min of ischaemia at a normal body temperature.25,26 As the
mean clamping time was just 20 min in group 2, the effect on
post-operative liver function was expected to be small. This short
clamp time would also explain the insignificant change in the
post-operative liver function between the two groups.
Possible explanations with regards to post-operative complica-
tions were a significantly higher blood loss and transfusion rate in
group 2. When we compared patients who received a transfusion
to patients who did not, the complication rate was significantly
higher in the former group. Besides, after exclusion of patients
receiving a transfusion in group 2, there was no statistical signifi-
cance in the complication rate between group 1 and 2. The sig-
nificant difference in the complication rate also explained the
longer hospital stay in group 2.
In subgroup analysis for patients with HCC who underwent a
right hepatectomy with curative intent, there was a significant
Table 3 List of complications
Group 1 (n = 58) Group 2 (n = 66)
Hepatic encephalopathy 0 4
Bile leakage 1 2
Liver failure 1 2
Renal failure 0 2
Pneumonia 0 2
Post-operative bleeding 0 2
Pleural effusion 1 9
Intra-abdominal collection 6 4
Wound infection 6 14
Others complicationsa 1 3
aOther complications included urinary tract infection, urinary retention,
incisional hernia, soleal vein thrombosis.
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improvement in overall and disease-free survival in group 1. The
3- and 5-year survival rates for HCC patients were 72% and 57%
in group 1, which were comparable to that around 60% and 40%
as reported from the literature with various surgical
techniques.27–29 The difference in blood loss and transfusion rate
may contribute to the survival difference between the two
groups. Univariate analysis from the present study showed that a
blood loss of more than 500 ml was a significant risk factor for
survival. Other studies also showed that operative blood loss and
peri-operative blood transfusion were important prognostic
factors on tumour recurrence and overall survival.30–33 However,
after excluding the patients who received a transfusion in group
2, the survival rate was still significantly lower than in group 1.
The result suggested that factors other than blood transfusion
would also contribute to the survival difference between the two
groups. In fact, results from the univariate and multivariate
analysis showed that HCC patients in the group using continu-
ous hilar clamping had a significantly poorer survival. From the
literature, data on the effect of ischaemic–reperfusion injury to
tumour recurrence and survival is still lacking. The authors pos-
tulate that it might be because of the improvement in the peri-
operative management between the two groups. Undoubtedly,
there were significant improvements in the surgical technique
and peri-operative management during the time interval
between group 1 and 2. It was a major confounding factor for
survival difference between the two groups. Besides, the differ-
ences in complication rate and post-operative liver function may
also contribute to the difference in survival between the two
groups.
Conclusions
With the improvement in dissecting instruments and surgical
technique, a change in practice from routine hilar clamping to no
clamping occurred for patients undergoing a right hepatectomy.
The change was made possible by adopting better haemostatic
instruments (CUSA and radiofrequency dissecting sealer) and a
meticulous technique of dissection.When compared with the ret-
Table 4 Baseline characteristics and tumour recurrence in hepatocellular carcinoma (HCC) patients
Group 1 (n = 36) Group 2 (n = 50) P-value
Baseline characteristics
Number of medical co-morbidity 0 (0–5) 0 (0–5) 0.320
Cirrhosis 13 (36.1%) 24 (48.0%) 0.272
Child's grading in cirrhotic patients (A/B) 13/0 23/1 1.000
Median blood loss (ml) 462 (100–1700) 930 (200–11745) <0.001a
Transfusion rate 4 (11.1%) 14 (29.8%) 0.041a
Tumour characteristics
Tumour size (cm) 6.3  2.7 6.5  3.3 0.713
Vascular invasion 11 (36.0%) 10 (20.0%) 0.171
Satellite lesions present 7 (19.4%) 9 (18.0%) 0.865
Resection margin (cm) 1.5  1.0 1.0  0.9 0.022a
Tumour differentiation 0.153
Well 9 (25.0%) 14 (28.5%)
Moderate 26 (72.2%) 28 (57.1%)
Poor 1 (2.8%) 7 (14.3%)
TNM staging 0.868
I 21 (58.3%) 32 (64.0%)
II 5 (13.9%) 6 (12.0%)
III 10 (27.8%) 12 (24.0%)
Tumour recurrence
Recurrence rate 13 (36.1%) 27 (54.0%) 0.101
Treatment for recurrence
Surgical resection 2 2
Trans-arterial therapy 1 4
Systemic chemotherapy 8 6
Local ablative therapy 1 1
aStatistically significant result (P < 0.05).
TNM, tumour node metastasis.
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rospective cohort, a right hepatectomy utilizing TissueLink™
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